How We're Keeping You Safe | What Patients & Families Need to Know

A photo of Michael Helmrath.

Surgical Director, Intestinal Rehabilitation Program

Director of Surgical Research
Associate Director of Clinical Translation, CuSTOM
Director, Center for Bariatric Research and Innovation
Pediatric Surgeon

Professor, UC Department of Surgery


Board Certified

Best Doctors logo

My Biography & Research


As a pediatric surgeon scientist, Dr. Helmrath has established a large multidisciplinary team dedicated to clinical, translational, and basic science research focused on human diseases. Clinically, he is dedicated to patients with intestinal diseases and obesity. In his laboratory he focuses on characterizing intestinal stem cells during intestinal adaptation and developing intestinal regenerative strategies. By combining his current roles as director of Surgical Research, director for the Center for Bariatric Research and Innovation, surgical director of the Intestinal Rehabilitation Program, and associate director of Clinical Translation for CuSTOM, his strong basic science research background further allows him to translate human GI conditions to the laboratory to develop highly innovative approaches to treat intestinal diseases.

Academic Affiliation

Professor, UC Department of Surgery


Colorectal Disorders, Surgery - General and Thoracic, Intestinal Disorders, Surgical Weight Loss, General and Thoracic Surgery

Cincinnati Children's Blog

Overcoming Natures Complexity to Help Patients with Intestinal Disease

BlogResearch and Discoveries

Overcoming Nature’s Complexity to Help Patients with Intestinal Disease

By Michael Helmrath, MD10/20/2014

Science Blog

Scientists Add Nerves to Intestinal Organoids


Scientists Add Nerves to Intestinal Organoids

Michael A. Helmrath, MD, MS, James M. Wells, PhD6/30/2019

My Locations

My Education

BA: Miami University, Oxford, OH, 1987.

MD: University of Cincinnati College of Medicine, Cincinnati, OH, 1993.

MS: University of Cincinnati College of Medicine, Cincinnati, OH, 1989.

Certification: Board-certified General Surgery; board-certified, Pediatric Surgery.

My Publications

Marked Variation Exists Among Surgeons and Hospitals in the Use of Secondary Cleft Lip Surgery. Sitzman, TJ; Carle, AC; Lundberg, JN; Heaton, PC; Helmrath, MA; Trotman, C; Britto, MT. The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association. 2020; 57:198-207.

Complications of bariatric surgery in adolescents. Lamoshi, A; Chernoguz, A; Harmon, CM; Helmrath, M. Seminars in Pediatric Surgery. 2020; 29:150888-150888.

Metabolic outcomes of surgery in youth with type 2 diabetes. Shah, AS; Nadeau, KJ; Helmrath, MA; Inge, TH; Xanthakos, SA; Kelsey, MM. Seminars in Pediatric Surgery. 2020; 29:150893-150893.

Changing the Paradigm for Management of Pediatric Primary Spontaneous Pneumothorax: A Simple Aspiration Test Predicts Need for Operation. Leys, CM; Hirschl, RB; Kohler, JE; Cherney-Stafford, L; Marka, N; Fallat, ME; Gadepalli, SK; Fraser, JD; Grabowski, J; Burns, RC; et al. Journal of Pediatric Surgery. 2020; 55:169-175.

Musculoskeletal pain, physical function, and quality of life after bariatric surgery. Bout-Tabaku, S; Gupta, R; Jenkins, TM; Ryder, JR; Baughcum, AE; Jackson, RD; Inge, TH; Dixon, JB; Helmrath, MA; Courcoulas, AP; et al. Pediatrics. 2019; 144:e20191399-e20191399.

IL-13–induced intestinal secretory epithelial cell antigen passages are required for IgE-mediated food-induced anaphylaxis. Noah, TK; Knoop, KA; McDonald, KG; Gustafsson, JK; Waggoner, L; Vanoni, S; Batie, M; Arora, K; Naren, AP; Wang, Y; et al. Journal of Allergy and Clinical Immunology. 2019; 144:1058-1073.e3.

Weight loss after sleeve gastrectomy in developmentally delayed adolescents and young adults. Goddard, GR; Kotagal, M; Jenkins, TM; Kollar, LM; Inge, TH; Helmrath, MA. Surgery for Obesity and Related Diseases. 2019; 15:1662-1667.

Five-Year Outcomes of Gastric Bypass in Adolescents as Compared with Adults Reply. Inge, TH; Courcoulas, AP; Helmrath, MA. The New England journal of medicine. 2019; 381:e17-e17.

VacA generates a protective intracellular reservoir for Helicobacter pylori that is eliminated by activation of the lysosomal calcium channel TRPML1. Capurro, MI; Greenfield, LK; Prashar, A; Xia, S; Abdullah, M; Wong, H; Zhong, XZ; Bertaux-Skeirik, N; Chakrabarti, J; Siddiquis, R; et al. Nature Microbiology. 2019; 4:1411-1423.

Multi-institutional trial of non-operative management and surgery for uncomplicated appendicitis in children: Design and rationale. Minneci, PC; Hade, EM; Lawrence, AE; Saito, JM; Mak, GZ; Hirschl, RB; Gadepalli, S; Helmrath, MA; Leys, CM; Sato, TT; et al. Contemporary Clinical Trials. 2019; 83:10-17.